ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,885.96
-0.29%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Carisma Therapeutics Inc (CARM) Share Price

CARM Carisma Therapeutics Inc

1.38
0.01 (0.73%)
18 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Carisma Therapeutics Inc NASDAQ:CARM NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.01 0.73 1.38 1.37 1.42 1.42 1.35 1.42 223,335 23:58:24   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 14.92M -86.88M -2.1528 -0.65 56.9M
 Type  Size  Price  Time  Units 
 9 50 1.42 23:57:08 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore CARM News
16/05/202412:30PRNUSCarisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte
09/05/202412:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202412:41EDGAR2Form 8-K - Current report
09/05/202412:30PRNUSCarisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
08/05/202416:45BWCarmila: Réduction des moyens du contrat de liquidité
08/05/202416:45BWCarmila: Withdrawal of funds for the liquidity contract
08/05/202412:30PRNUSCarisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024
Period
Draw mode
Data Downloads for CARM

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Carisma Therapeutics Inc Articles